×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
NASDAQ:OFIX

Orthofix Medical Stock Forecast, Price & News

$23.55
-0.20 (-0.84%)
(As of 06/29/2022 05:49 PM ET)
Add
Compare
Today's Range
$23.36
$24.05
50-Day Range
$23.55
$34.85
52-Week Range
$23.36
$43.30
Volume
85,898 shs
Average Volume
102,593 shs
Market Capitalization
$468.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00
30 days | 90 days | 365 days | Advanced Chart

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Stock Forecast (MarketRank)

Overall MarketRank

2.11 out of 5 stars

Medical Sector

483rd out of 1,432 stocks

Surgical & Medical Instruments Industry

57th out of 137 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
Orthofix Medical logo

About Orthofix Medical (NASDAQ:OFIX)

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OFIX Stock News Headlines

Orthofix Medical (NASDAQ:OFIX) Hits New 1-Year Low at $26.05
Orthofix Reports First Quarter 2022 Results
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,087
Year Founded
1980

Company Calendar

Last Earnings
5/06/2022
Today
6/29/2022
Next Earnings (Estimated)
8/05/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$45.00
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$45.00
Forecasted Upside/Downside
+91.1%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
1 Analysts

Profitability

Net Income
$-38.38 million
Pretax Margin
-2.55%

Debt

Sales & Book Value

Annual Sales
$464.48 million
Cash Flow
$3.01 per share
Book Value
$16.99 per share

Miscellaneous

Free Float
19,215,000
Market Cap
$468.93 million
Optionable
Optionable
Beta
0.97

Social Links















Orthofix Medical Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Orthofix Medical stock.
View analyst ratings for Orthofix Medical
or view top-rated stocks.

What is Orthofix Medical's stock price forecast for 2022?

1 Wall Street research analysts have issued 1 year target prices for Orthofix Medical's stock. Their OFIX stock forecasts range from $45.00 to $45.00. On average, they anticipate Orthofix Medical's stock price to reach $45.00 in the next year. This suggests a possible upside of 91.1% from the stock's current price.
View analysts' price targets for Orthofix Medical
or view top-rated stocks among Wall Street analysts.

How has Orthofix Medical's stock price performed in 2022?

Orthofix Medical's stock was trading at $31.09 at the beginning of the year. Since then, OFIX shares have decreased by 24.3% and is now trading at $23.55.
View the best growth stocks for 2022 here
.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Orthofix Medical
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, May, 6th. The medical device company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.18 by $0.28. The medical device company earned $106.42 million during the quarter, compared to the consensus estimate of $104.70 million. Orthofix Medical had a positive trailing twelve-month return on equity of 3.34% and a negative net margin of 7.96%.
View Orthofix Medical's earnings history
.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share (EPS) guidance of $0.58-$0.73 for the period, compared to the consensus earnings per share estimate of $0.66. The company issued revenue guidance of $475.00 million-$490.00 million, compared to the consensus revenue estimate of $481.93 million.

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Jon C. Serbousek, Pres, CEO & Director (Age 61, Pay $1.61M)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 56, Pay $782.49k)
  • Ms. Kimberley A. Elting, Chief Legal & Devel. Officer and Pres of the Global Orthopedics (Age 57, Pay $781.15k) (LinkedIn Profile)
  • Mr. Kevin J. Kenny, Pres of Global Spine Bus. (Age 57, Pay $778.96k)
  • Mr. Roberto Donadello, Sr. VP of Global Operations
  • Dr. James T. Ryaby B.A., Chemistry, Ph.D., Chief Scientific Officer (Age 63)
  • Mr. Dan E. Yarbrough, VP of Investor Relations
  • Ms. Jill Mason, Chief Ethics & Compliance Officer
  • Ms. Suzanne Armstrong, VP of HR
  • Mr. Ehab M. Esmail, Sr. VP of Quality, Regulatory & Clinical Affairs (Age 50)

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical CEO Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among Orthofix Medical's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (17.25%), Vanguard Group Inc. (10.80%), Paradice Investment Management LLC (5.06%), State Street Corp (3.98%), Polar Asset Management Partners Inc. (3.70%) and Dimensional Fund Advisors LP (3.37%). Company insiders that own Orthofix Medical stock include Brad Mason, Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug and Ronald A Matricaria.
View institutional ownership trends for Orthofix Medical
.

Which major investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Polar Asset Management Partners Inc., Arrowstreet Capital Limited Partnership, State Street Corp, State of New Jersey Common Pension Fund D, Royce & Associates LP, Gabelli Funds LLC, Gabelli Funds LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for Orthofix Medical
or view top insider-selling stocks.

Which major investors are buying Orthofix Medical stock?

OFIX stock was bought by a variety of institutional investors in the last quarter, including Endurant Capital Management LP, Heartland Advisors Inc., Dimensional Fund Advisors LP, Victory Capital Management Inc., Paradigm Capital Management Inc. NY, First Eagle Investment Management LLC, BlackRock Inc., and Engineers Gate Manager LP. Company insiders that have bought Orthofix Medical stock in the last two years include Catherine M Burzik, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, and Rice Doug.
View insider buying and selling activity for Orthofix Medical
or or view top insider-buying stocks.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $23.55.

How much money does Orthofix Medical make?

Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $468.93 million and generates $464.48 million in revenue each year. The medical device company earns $-38.38 million in net income (profit) each year or ($1.860010) on an earnings per share basis.

How many employees does Orthofix Medical have?

Orthofix Medical employs 1,087 workers across the globe.

When was Orthofix Medical founded?

Orthofix Medical was founded in 1980.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for Orthofix Medical is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at [email protected], or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.